Kolexia
Rebischung Christine Oncologie médicale
Rebischung Christine
Oncologie médicale
Cabinet libéral
Challes-les-Eaux, France
62 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénocarcinome Tumeurs du pancréas Métastase tumorale Tumeurs colorectales Tumeurs du foie Tumeurs de l'estomac Tumeurs du côlon Carcinomes Neutropénie

Collaborateurs

Voir plus
Mille Dominique
Mille Dominique
Cabinet libéral, Challes-les-Eaux, France
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France
De La Fouchardiere Christelle
De La Fouchardiere Christelle
Centre Paoli-Calmettes, Marseille, France
Louvet Christophe
Louvet Christophe
Institut Mutualiste Montsouris, Paris, France

Industries

Voir plus
Ipsen
5 collaboration(s)
Dernière en 2023
MSD
5 collaboration(s)
Dernière en 2023
Servier
4 collaboration(s)
Dernière en 2022
Sanofi
4 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
POCHI: Pembrolizumab in Combination With Xelox Bevacizumab in Patients With Microsatellite Stable Mestatic Colorectal Cancer and a High Immune Infiltrate : a Proof of Concept Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
PANOPTIMOX: Randomised Phase II Study in Metastatic Pancreatic Cancer Evaluating FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem in First-line
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   18 août 2022
Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   21 juillet 2021
Management of Patients with Pancreatic Ductal Adenocarcinoma in the Real-Life Setting: Lessons from the French National Hospital Database.
Cancers   14 juillet 2021
Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial' European Journal of Cancer, Volume 124 (January 2020) Pages 91-101.
European journal of cancer (Oxford, England : 1990)   06 mars 2020
Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial.
European journal of cancer (Oxford, England : 1990)   21 novembre 2019
Exploratory analyses of 400 patients enrolled in 2 FFCD trials of first line treatment for metastatic pancreatic cancer
Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany   01 octobre 2018
How to predict the relapse after surgery or radiofrequency of liver metastases of colorectal cancer? Interest of the serum kinetic variation of a matrix metalloproteinase cluster.
Bulletin du cancer   20 septembre 2018
Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma: Phase II, Randomized, Controlled, Clinical Trial Exploring Efficacy and Safety of ERY001 (L-asparaginase Encapsulated in Red Blood Cells) in Association With Gemcitabine or FOLFOX4 in Second-line Therapy for Patients With Progressive Metastatic Pancreatic Carcinoma
Essai Clinique (Erytech Pharma)   25 juillet 2018
FOLFIRINOX until progression, FOLFIRINOX with maintenance treatment, or sequential treatment with gemcitabine and FOLFIRI.3 for first-line treatment of metastatic pancreatic cancer: A randomized phase II trial (PRODIGE 35-PANOPTIMOX).
2018 ASCO Annual Meeting I   01 juin 2018